Polyphenols selectively reverse early-life stress-induced behavioural, neurochemical and microbiota changes in the rat by Donoso, Francisco et al.
UCC Library and UCC researchers have made this item openly available.
Please let us know how this has helped you. Thanks!
Title Polyphenols selectively reverse early-life stress-induced behavioural,
neurochemical and microbiota changes in the rat
Author(s) Donoso, Francisco; Egerton, Sian; Bastiaanssen, Thomaz F. S.;
Fitzgerald, Patrick; Gite, Snehal; Fouhy, Fiona; Ross, R. Paul; Stanton,
Catherine; Dinan, Timothy G.; Cryan, John F.
Publication date 2020-04-10
Original citation Donoso, F., Egerton, S., Bastiaanssen, T. F. S., Fitzgerald, P., Gite, S.,
Fouhy, F., Ross, R. P., Stanton, C., Dinan, T. G. and Cryan, J. F. (2020)
'Polyphenols selectively reverse early-life stress-induced behavioural,
neurochemical and microbiota changes in the rat',
Psychoneuroendocrinology, 116, 104673 (12pp). doi:
10.1016/j.psyneuen.2020.104673




Access to the full text of the published version may require a
subscription.
Rights © 2020, Elsevier Ltd. All rights reserved. This manuscript version is
made available under the CC BY-NC-ND 4.0 license.
https://creativecommons.org/licenses/by-nc-nd/4.0/
Embargo information Access to this article is restricted until 12 months after publication by
request of the publisher.






Polyphenols Selectively Reverse Early-Life Stress-Induced Behavioural,
Neurochemical and Microbiota Changes in the Rat
Francisco Donoso, Sian Egerton, Thomaz F.S. Bastiaanssen,
Patrick Fitzgerald, Snehal Gite, Fiona Fouhy, R. Paul Ross,




To appear in: Psychoneuroendocrinology
Received Date: 13 December 2019
Revised Date: 7 February 2020
Accepted Date: 25 March 2020
Please cite this article as: Donoso F, Egerton S, Bastiaanssen TFS, Fitzgerald P, Gite S,
Fouhy F, Ross RP, Stanton C, Dinan TG, Cryan JF, Polyphenols Selectively Reverse Early-Life
Stress-Induced Behavioural, Neurochemical and Microbiota Changes in the Rat,
Psychoneuroendocrinology (2020), doi: https://doi.org/10.1016/j.psyneuen.2020.104673
This is a PDF file of an article that has undergone enhancements after acceptance, such as
the addition of a cover page and metadata, and formatting for readability, but it is not yet the
definitive version of record. This version will undergo additional copyediting, typesetting and
review before it is published in its final form, but we are providing this version to give early
visibility of the article. Please note that, during the production process, errors may be
discovered which could affect the content, and all legal disclaimers that apply to the journal
pertain.
© 2020 Published by Elsevier.
Polyphenols Selectively Reverse Early-Life Stress-
Induced Behavioural, Neurochemical and Microbiota 
Changes in the Rat 
Francisco Donosoa, b, Sian Egertona, d, e, Thomaz F. S. Bastiaanssena, c, Patrick Fitzgeralda, c, 
Snehal Gited, Fiona Fouhyd, R. Paul Rossa, Catherine Stantona, d, Timothy G. Dinana, b and John 
F. Cryana, c 
aAPC Microbiome Ireland, University College Cork, Cork, Ireland                 
bDepartment of Psychiatry & Neurobehavioural Science, University College Cork, Cork, 
Ireland           
cDepartment of Anatomy & Neuroscience, University College Cork, Cork, Ireland.  
dTeagasc Food Research Centre, Moorepark, Fermoy, Co. Cork, Ireland. 
eSchool of Biological, Earth and Environmental Science, University College, Cork, Ireland. 
 
Correspondence: Prof. John F. Cryan, Dept. Anatomy & Neuroscience/APC Microbiome 
Ireland, University College Cork, Ireland (j.cryan@ucc.ie) 
Highlights 
 Dietary polyphenols prevented depressive- and anxiety-like behaviours in rats exposed 
to early life stress. 
 A polyphenolic diet ameliorated a dysregulation of the HPA axis and BDNF levels in 
rats subjected to early life stress. 
 Dietary polyphenols reversed early life stress-induced changes in gut microbiota 
composition.  
 Polyphenol-driven improvements in behaviour and physiology may be mediated by 












There is a growing emphasis on the role of the microbiota-gut-brain axis as modulator of host 
behaviour and as therapeutic target for neuropsychiatric disorders. In addition, accumulating 
evidence suggests that early-life stress can exert long-lasting changes on the brain and 
microbiota, and this early adversity is associated with increased risk for developing depression 
in later life. The maternal separation (MS) model in rats is a robust paradigm to study the effects 
of early-life stress on the microbiota-gut-brain axis. Recently, we have shown that   
polyphenols, naturally occurring compounds associated with several health benefits, have anti-
stress effects in in vitro models. In this study, we assess the therapeutic potential of a variety 
of both flavonoid and non-flavonoid polyphenols in reversing the impact of MS on behaviour 
and the microbiota-gut-brain axis. 
Rats underwent a dietary intervention with the naturally-derived polyphenols xanthohumol and 
quercetin, as well as with a phlorotannin extract for 8 weeks. Treatment with polyphenols 
prevented the depressive and anxiety-like behaviours induced by MS, where xanthohumol 
effects were correlated with rescue of BDNF plasma levels. In addition, MS resulted in altered 
brain levels of 5-hydroxyindoleacetic acid (5-HIAA) and dopamine, accompanied by abnormal 
elevation of plasma corticosterone. Although polyphenols did not reverse neurotransmitter 
imbalance, xanthohumol normalised corticosterone levels in MS rats. Finally, we explored the 
impact of MS and polyphenolic diets on the gut microbiota. We observed profound changes in 
microbial composition and diversity produced by MS condition and by xanthohumol treatment. 
Moreover, functional prediction analysis revealed that MS results in altered enrichment of 
pathways associated with microbiota-brain interactions that are significantly reversed by 
xanthohumol treatment. These results suggest that naturally-derived polyphenols exert 
antidepressant-like effects in MS rats, which mechanisms could be potentially mediated by 




















Stress-related psychiatric disorders including depression and anxiety are currently a major 
public health concern. Indeed, the World Health Organisation (WHO) has predicted that 
depression will be the second largest cause of disability by 2020 (Johnston et al., 2019). On the 
other hand, major depressive disorder is thought to result from the complex interplay of 
multiple inherited genetic factors and subsequent exposure to a wide range of environmental 
variables throughout life (aan het Rot et al., 2009); therefore, the search for adequate treatments 
is a great challenge as no established mechanisms have yet been determined (Berton and 
Nestler, 2006). Based on these observations and considering that depression has an inconsistent 
response to treatment, the development of new antidepressant strategies is increasingly being 
considered as a critical focus of research. 
It is well known that stressful events in early life can exert long-lasting changes in brain 
structure and function later on (Cryan and Dinan, 2013) and accumulating evidence indicates 
that this early life adversity is associated with an increased risk for developing depression 
(Chapman et al., 2004; Heim and Binder, 2012). For instance, inadequate maternal care has 
been linked to developmental, emotional and social deficits in humans (Field, 1998). In rodents, 
the maternal separation (MS) model is a well-described paradigm used to investigate the 
neurobiological and behavioural consequences of early life stress (Nishi et al., 2014; O'Mahony 
et al., 2011; Rincel and Darnaudery, 2019). For this reason, the MS model has been used to 
study various psychiatric conditions, especially depression (Vetulani, 2013)(Meaney et al., 








The microbiota-gut-brain axis describes the complex bidirectional communication system that 
exists between the central nervous system (CNS) and enteric microbiota; involving endocrine, 
immune and neural pathways (Cryan et al., 2019; Foster et al., 2017; Rhee et al., 2009). 
Accumulating research has focused on the impact of the microbiota on CNS function and stress 
perception, and its consequences for behaviour (Cryan and Dinan, 2012). Indeed, top down 
activation of the CNS can influence gut neuromotor and secretory function, immunity and 
microbiota composition during stress (De Palma et al., 2014; Foster et al., 2017). In this regard, 
early-life stress models such as MS have long-term impact on the gut microbiota, which 
correlate with increased HPA axis activity and behaviour (Bailey and Coe, 1999; O'Mahony et 
al., 2009). Moreover, the MS model is sensitive to reversal treatments that target the gut 
microbiota (Cowan et al., 2019; Fukui et al., 2018; Gareau et al., 2007; McVey Neufeld et al., 
2019; O'Mahony et al., 2019). 
The emerging and compelling evidence for nutrition as a crucial factor in the high prevalence 
and incidence of mental disorders suggests that changes in diet are a viable strategy for 
improving mental health and treatment of psychiatric disorders including anxiety and 
depression (Adan et al., 2019; Dinan et al., 2019; Jacka et al., 2014; Lai et al., 2014; Larrieu 
and Laye, 2018; Spencer et al., 2017). For instance, dietary polyphenols are a group of naturally 
occurring phytochemicals which are present in high amounts in fruits and vegetables and are 
characterised by the presence of multiple hydroxyl groups on aromatic rings (Vauzour, 2012). 
Several studies have focused on the potential of polyphenolic compounds in protecting 
cognitive function and reducing risk for developing neurodegenerative disorders (Spencer, 
2008). In particular, some pre-clinical studies have confirmed the antidepressant capacity of 
polyphenols in different animal models (Anjaneyulu et al., 2003; Kulkarni et al., 2008; Yi et 
al., 2008). Moreover, dietary polyphenols are capable of modulating the composition of the gut 









2006). Hence, there is increasing interest in using polyphenols to target the microbiota-gut-
brain axis to treat mental disorders (Filosa et al., 2018; Matarazzo et al., 2018). 
Polyphenolic compounds are characterised as having different functional activity depending 
on their chemical structure (Manach et al., 2004; Vauzour et al., 2010). For instance, 
phlorotannins are a type of polyphenolic tannins found in marine brown algae, which have been 
shown to possess anti-oxidant activity, as well as beneficial effects for different diseases such 
as cancer, cardiovascular problems and diabetes (Kim and Himaya, 2011). Other polyphenols 
can only be isolated from specific sources. Xanthohumol, for example, is described as a 
prenylated chalcone, a principal component of the female hop plant, Humulus lupulus (Stevens 
and Page, 2004). Some health benefits associated with xanthohumol intake include anti-
inflammatory and neuroprotective effects (Liu et al., 2015). In contrast, some members of the 
flavonoid family like quercetin are widely distributed in nature (Manach et al., 2004). 
Quercetin is one of the most studied polyphenols and has been demonstrated to confer 
protection against certain types of cancer, cardiovascular and neurodegenerative disorders 
(Boots et al., 2008). 
Recently, we showed that across a wide number of polyphenols, xanthohumol and quercetin 
were able to reverse the impact of corticosterone exposure in primary cortical neurons (Donoso 
et al., 2019). Moreover, although the antidepressant effects of several polyphenols have been 
studied in different preclinical studies (Bhutada et al., 2010; Liu et al., 2014; Xu et al., 2005), 
their therapeutic effects have not yet been examined in models of early life stress, nor the 
mechanisms underlying the polyphenol-mediated alleviation of mood. Therefore, the purpose 
of this study was to explore the therapeutic effects of different naturally derived polyphenols, 









consequences of MS and polyphenol diet intervention on different aspects of the microbiota-
gut-brain axis were explored.  
In this regard, we evaluated important components involved in the regulation of this axis, 
including BDNF, which is a crucial neurotrophin associated with plasticity and neuronal 
survival (Brunoni et al., 2008; Lee and Kim, 2010); the assessment of neurotransmitter 
concentrations in the brainstem, an important brain locus for monoaminergic transmission and 
which is implicated in mood disorders (Sasaki et al., 2008), as well as highly influenced by the 
gut microbiota (Strandwitz, 2018); and the response to acute stress through the determination 
of plasma corticosterone, the main rodent stress hormone (de Kloet et al., 2005; Joels et al., 
2018). Finally, we evaluated the consequences of MS and diet intervention with polyphenols 
on the gut microbiota abundance and through the determination of short-chain fatty acids 
(SCFAs), microbial metabolites thought to play a critical role in gut-brain communication 
(Dalile et al., 2019; van de Wouw et al., 2018). Together, findings from this study have the 
potential to provide new insights into the potential therapeutic effects of polyphenols and the 
role of the microbiota-gut-brain axis in stress-related disorders, and add an important direction 
to future dietary advice on optimal nutrition for mental health and to counter the enduring 












All experimental procedures involving animals were approved by the Ethics Committee of 
University College Cork. Pregnant Sprague Dawley dams weighing 250–300 g were bred in-
house in the Biological Services Unit facility, University College Cork. The pups were housed 
with their mothers in plastic cages (15 × 22 × 9 cm) in a temperature and humidity controlled 
room on a 12-h light, 12-h dark cycle (lights on from 7.00–19.00 h). Food and water were 
available ad libitum. 
2.2 Drugs 
Quercetin (Q4951) was purchased from Sigma. Xanthohumol (A-4-2014) was provided by 
Hopsteiner, GmbH (Mainburg, Germany). Phlorotannin-rich extract from Fucus vesiculosus 
(Gite et al., 2019) was obtained from National University of Ireland, Galway (Galway, Ireland). 
All diets were prepared by ssniff Spezialdiäten (Ferdinand-Gabriel-Weg, Germany). The 
resulting grain based chows were isoenergetic and had the same proportion of macronutrients 
(carbohydrates, proteins and lipids). 
2.3 Maternal separation procedure 
MS was performed as previously described (O'Mahony et al., 2009; Pusceddu et al., 2015). 
Briefly, pups were separated from their mother as a whole litter and placed into plastic cages 
maintained at 30 – 33 °C in a separate room to prevent communication through ultrasonic 
vocalisation (Hofer et al., 1994). Following the 3-hour separation, pups were returned to their 
original home cage with their mother. This procedure was repeated each day (9.00am–
12.00pm) from post-natal day (PND) 2 through PND12. NS-Control rats consisted of non-









postnatal day 12, pups were left undisturbed except for routine cage cleaning every two days. 
At weaning, male rats were group-housed (2 – 4) in large cages. 
2.4 Treatments 
The rats were randomly assigned into five different experimental groups [1] NS-Control diet 
(n = 12); [2] MS-Control diet (n = 12); [3] MS-Phlorotannins 0.03% (n = 10); [4] MS-
Xanthohumol 0.015% (n = 10); [5] MS-Quercetin 0.03% (n = 10). Dietary intervention of 
polyphenols, delivered ad libitum in food, began once the animals were eight weeks old and 
continued for eight weeks. The concentrations for the polyphenols tested were calculated based 
on doses previously reported in animal models and considered the average daily food intake 
and body weight of Sprague Dawley rats aged between 9 and 16 weeks (Laaksonen et al., 
2013). Estimated doses are as follows; quercetin 20 mg/kg/day (Haleagrahara et al., 2009); 
xanthohumol 10 mg/kg/day (Ceremuga et al., 2013); phlorotannins 20 mg/kg/day (Ahn et al., 
2017). In the interest of reduction in the 3Rs a number of other interventions were also run 
contemporaneously with the control and treatment groups used here (Egerton et al. 
unpublished). 
2.5 Elevated plus maze 
The elevated plus maze (EPM) is one of the most commonly used rodent tests for assessing 
anxiety and was performed as previously described (Cryan et al., 2004; Pusceddu et al., 2015). 
Briefly, the maze consisted of two open arms (51 × 10 cm; 5 lux) and two enclosed arms (51 
× 10 × 41 cm) that all extended from a common central platform (10 × 10 cm). The apparatus 
was elevated 55 cm above the floor on a central pedestal. Animals were habituated to the testing 
room for 30 min prior experiment. At week 12, animals were placed in the centre of the maze 
facing an open arm to begin. Animal behaviour was recorded for 5 min. Frequency of open and 









2.6 Open field test 
The open field test (OFT) is commonly used as a mechanism to assess anxiolytic effects of 
compounds (Seibenhener and Wooten, 2015). Briefly, at week 13 rats were placed in the centre 
of a white open field arena (60 × 40 cm; 60 lux) and observed for 10 min. Animals were 
habituated to the test room for 30 min prior to the experiment. All trials were conducted 
between 9.00am and 1.00pm. The arena was cleaned with 70% ethanol to avoid smell cues 
between each trial. At the end of each trial, animals were returned to their cages. Distance 
moved, velocity, percentage of time spent in inner zone, and frequency of inner zone entries 
were analysed and recorded using a tracking system (Ethovision XT 13, Noldus). 
2.7 Forced swim test 
The forced swim test (FST) is the most widely used model for predicting antidepressant activity 
in rodents, and increased immobility in this test is generally considered to reflect a state of 
behavioural despair (Porsolt et al., 1978). Briefly, at week 15 a modified rat FST protocol 
(Slattery and Cryan, 2012) was used to determine the antidepressant effects of polyphenols in 
rats. On day one, rats were placed individually in glass cylinders (H: 45 cm; D: 20 cm) filled 
with water to a depth of 30 cm at 24±1 °C for a 15 min pre-test period. The rats were removed 
from the water, dried and placed in their home cage. The cylinders of water were changed 
between each trial. 24 hours after the pre-test, the rats were again placed in the swim apparatus 
for 5 min and behaviours were monitored from above with a video camera for subsequent 
analysis. Behaviours rated include immobility, climbing and swimming (scoring of behaviours 
was blind to the experimental conditions). The 5-min session was scored using a time-sampling 
technique, whereby the predominant behaviour in each 5-s period of the 300-s trial was 
recorded. Climbing behaviour consisted of upward-directed movements of the forepaws along 









throughout the cylinder. The rat was considered to be immobile when the only activity observed 
was that which was required by the rat to keep its nose above water. 
2.8 Plasma corticosterone determination 
Blood sample collection was performed as previously described (Pusceddu et al., 2015). 
Briefly, blood samples were collected on day one of FST via a tail-tip incision at five different 
time points: immediately before (baseline), 30 min, 60 min, 90 min and 120 min after the test 
was started. Approximately 200 µl of blood was collected in a tube containing 10 µL of EDTA 
0.1 M to avoid coagulation. Blood plasma was obtained by centrifugation at 3500 × g at 4 °C 
for 15 min. Corticosterone levels were measured using the Corticosterone EIA kit (Enzo) 
according to the manufacturer instructions, and absorbance signal was detected with a 
conventional plate reader (Synergy HT, Biotek). 
2.9 Plasma BDNF measurement 
Immediately after sacrifice, trunk blood was collected in EDTA Vacutainer tubes. Blood 
plasma was obtained by centrifugation at 3500 × g at 4 °C for 15 min. Protein levels of brain-
derived neurotrophic factor (BDNF) were determined using an electrochemiluminescence 
multiplex system (MSD, Gaithersburg, MD, USA) according to the manufacturer’s protocol. 
BDNF levels were determined and analysed using the MSD QuickPlex SQ 120 Instrument. 
2.10  Brain monoamines concentration 
The monoamine neurotransmitters noradrenaline (NA), serotonin (5-HT), dopamine (DA) and 
their metabolites 5-HIAA and 3,4-dihydroxyphenylacetic acid (DOPAC) were determined in 
the brainstem using high-performance liquid chromatography (HPLC) with electrochemical 
detection as described previously (Clarke et al., 2012; Pusceddu et al., 2015). Briefly, samples 









phosphate monohydrate, 5.6 mM 1-octanesulfonic acid, 0.01 mM EDTA, 11.1% (v/v) 
methanol, and 0.1 µg/mL of N-Methyl 5-HT as internal standard and adjusted to pH 2.8). Then 
samples were centrifuged 14000 g for 15 min at 4 °C, and 20 µL of this supernatant was injected 
onto the HPLC system (consisting in a CBM-20A system controller, a EC3000 Recipe 
amperometric detector, a LC-20AD XR pump, a CTO-20A column oven at 30 ⁰C, a SIL-20AC 
XR autosampler, and a Prominence DGU-20A3 degasser). A reverse-phase column (Kinetex 
2.6u C18 100A 100 mm X 4.6 mm, Phenomenex) was employed in the separation using a flow 
rate of 0.9 mL/min. Each neurotransmitter was identified through their characteristic retention 
times and their concentration was determined using the ratios of peak heights of analyte versus 
internal standard provided by the LabSolutions software (Shimadzu). Results were expressed 
as nanograms of neurotransmitter per grams of fresh tissue. 
2.11  Gut microbiota 16S rRNA sequencing 
Microbial DNA was isolated from frozen faecal samples using the QIAGEN QIAamp Fast 
DNA Stool Mini Kit (Qiagen) according to the manufacturer’s directions. DNA concentration 
and quality was determined using the NanoDrop® ND-1000 UV-Vis Spectrophotometer 
(Thermo Fisher Scientific). The V3-V4 variable region of the 16S rRNA gene was amplified 
from the DNA extracts using the Illumina 16S metagenomic sequencing library protocol, and 
PCR reactions were performed with the KAPA HiFi HotStart PCR Kit (KAPA Biosystems). 
PCR products were cleaned using AMPure XP magnetic bead-based purification (Beckman 
Coulter Life Sciences). This was followed by indexing PCR which attached Nextera XT 
barcodes and Illumina sequencing adapters to the 5′ overhangs and another round of AMPure 
XP clean-up. Finally, samples were sequenced on the MiSeq™ System (Illumina®), using a 2 










2.12  Short chain fatty acid determination 
The SCFAs acetate, propionate, butyrate, and valerate, as well as the total branched chain fatty 
acids (BCFAs) were measured in caecal content using gas chromatography flame ionisation 
detection (GC-FID) as previously reported (van de Wouw et al., 2018). Briefly, samples were 
vortexed with Milli-Q water (1:10 w/v), left to stand for 10 min at room temperature, and then 
centrifuged at 14000 g for 5 min. The supernatant was filtered (0.2 µm) before transfer to a GC 
glass vial, and 2-ethylbutyric acid (Sigma) was added as internal standard.  SCFA 
concentrations were measured using a Varian CP-3800 GC flame-ionization system, fitted with 
a Zebron ZB-FFAP column (30 m × 0.32 mm × 0.25 µm; Phenomenex) and a flame ionisation 
detector with a CP‐8400 auto‐sampler. Helium was used as the carrier gas at a flow rate of 1.3 
ml/min. The initial oven temperature was set at 100 °C for 0.5 min, raised to 180 °C at 8 °C/min 
and held for 1 min, then increased to 200 °C at 20 °C/min, and finally held at 200 °C for 5 min. 
The temperature of the injector and the detector were set at 240 °C and 250 °C respectively. A 
standard curve made from a standard mix of acetic acid, propionic acid, n-butyric acid and iso-
butyric acid (Sigma) at seven concentrations. Peaks were integrated by using the Varian Star 
Chromatography Workstation version 6.0 software. Standards were included in each run to 
maintain calibration. 
2.13  Statistical analysis 
Statistical analysis was performed using the software SPSS 24.0, and the results were presented 
as mean ± SEM. MS-control group and NS-control group were compared using independent 
T-test to assess the MS effect. All MS groups were analysed using one-way analysis of variance 
(ANOVA) followed by Dunnett’s post hoc test. A p-value of 0.05 was considered statistically 
significant. FLASH was used to assemble paired-end reads. Further processing of paired-end 
reads including quality filtering based on a quality score of >25 and removal of mismatched 









Denoising, chimera detection and clustering into operational taxonomic unit (OTU) grouping 
were performed using USEARCH v7 (64-bit). OTUs were aligned using PyNAST, and 
taxonomy was assigned using BLAST against the SILVA SSURef database release 123. 
Statistical microbiome analysis was carried out in R (version 3.6.1) with Rstudio (version 
1.2.1335). OTUs unknown on a genus level were excluded, as well as OTUs available in two 
or fewer samples. The ALDEx2 library (Fernandes et al., 2014) was used to compute the 
centred log-ratio transformed values of the remaining taxa. For principal component analysis, 
a pairwise implementation of the adonis() PERMANOVA function in the vegan library 
(Oksanen et al., 2017) followed by the Bonferroni-Holm correction was used to test for 
difference in β-diversity in terms of Aitchison distance. Differential abundance was assessed 
using a pairwise implementation of the aldex.test() function, followed by Benjamini-Hochberg 
correction. In these cases, a q-value < 0.1 was considered significant. α-diversity was computed 
using the iNEXT library (Hsieh et al., 2016). 
2.14  Functional prediction of Gut-Brain modules 
The Piphillin webservice (Iwai et al., 2016) was used to infer the functional metagenome per 
sample in terms of KEGG orthologues. Next, these KEGG orthologues were processed using 
the omixer library in R (Darzi et al., 2016) in order to calculate  abundance of gut-brain-
modules (GBMs) (Valles-Colomer et al., 2019) and gut-metabolic modules (GMMs) in these 
samples. Then, the same implementation from ALDEx2 was used to assess differential 
abundance. Scripts are publicly available on GitHub: 











3.1 Polyphenols reversed MS-induced depressive-like behaviours 
To investigate the therapeutic effects of the dietary interventions with polyphenols from MS-
induced behavioural despair, animals were subjected to a battery of behavioural tests to 
examine depressive- and anxiety-like behaviours. Firstly, animals did not differ in terms of 
body weight across the different experimental groups throughout the duration of the treatment 
(Fig. 1B and C). In FST, analysis yielded a significant effect of MS compared to NS-control 
group on the time spent immobile (t22 = -2.349; p = .028) and swimming (t22 = 2.611; p = .016) 
(Fig. 2A). MS animals exhibited improved depressive-like behaviours with xanthohumol; 
moreover, quercetin and phlorotannins significantly decreased immobility time in the FST 
(F3,36 = 4.425; p = .05 and p = .002 respectively). In addition, treatment with phlorotannins 











Figure 1 Diet intervention with polyphenols did not affect body weight. (A) Schematic representing the 
experimental timeline. (B) Body weight was measured weekly from 6-week old until the end of the diet 
intervention. (C) The weight gain was calculated as the difference between the first body weight record (6 weeks) 
and the last measurement (15 weeks). 
3.2 Polyphenols showed anxiolytic potential in MS animals 
MS-induced anxiety-like behaviour in the OFT by significantly reducing the time spent in the 
centre (t21 = 2.156; p = .025), as well as in the number of entries in the centre of the arena (t21 
= 2.855; p = .009) (Fig.2D and E). Administration of quercetin in MS rats resulted in a 
significant increase in the number of entries in the open arms compared to the MS-control 
group (F3,38 = 2.714; p = .040), which was associated with an anxiolytic effect (Fig. 2G). 
Interestingly, treatment with phlorotannins ameliorated MS-induced anxiogenic effects in both, 
time in centre (F3,37 = 2.297; p = .025) and in entries into the centre (F3,37 = 2.405; p = .025). 
However, no differences were found between NS-control and MS animals during the EPM 
(Fig. 2F and G). 
 
Figure 2 Treatment with polyphenols induced antidepressant- and anxiolytic-like effects in MS rats. (A) MS-
induced increased immobility in the FST is prevented through treatment with quercetin and phlorotannins, while 
reduced swimming time caused by MS is reversed only by phlorotannins treatment. (B – C) Polyphenolic diets 
nor MS produced changes in locomotor activity. (D – E) Phlorotannins treatment produced a significant increase 
in the time spent in centre and number of centre entries when is compared to MS-control group in the OFT. (F – 
G) However, MS animals did not show anxiety-like behaviours in the EPM. Results are expressed as the mean ± 









3.3 Xanthohumol prevented the exacerbated corticosterone production in 
MS rats after acute stress 
To determine the role of the HPA axis in MS-induced depressive- and anxiety-like behaviours, 
the concentration of corticosterone in plasma was measured at different time points after an 
acute stress (Fig. 3A). Indeed, the corticosterone production was close to being statistically 
increased in MS-control relative to the NS-control group as revealed by the area under the 
curve (AUC) of corticosterone response (t20 = -1.949; p = .065) (Fig. 3B). Interestingly, dietary 
intervention with xanthohumol in MS animals induced a significant reduction in corticosterone 
AUC compared to the MS-control group (F3,34 = 3.827; p = .010) (Fig. 3B). In addition, all 
polyphenolic treatments induced lower baseline levels of plasma corticosterone compared to 
MS-control group (F3,36 = 3.979; quercetin p = .080; xanthohumol p = .006; phlorotannins p = 
.011). 
3.4 MS-induced plasma BDNF reduction was reversed by xanthohumol 
treatment 
BDNF is a critical modulator of neuroplasticity and survival, abundant in the brain and 
periphery, including serum and plasma (Lee and Kim, 2010). Preclinical and clinical studies 
have demonstrated that chronic stress and depressive status reduces BDNF expression (Gonul 
et al., 2005; Russo-Neustadt et al., 2001). Indeed, MS rats showed lower levels of plasma 
BDNF compared to NS animals (t19 = 2.672; p = .015), and this effect was significantly 










Figure 3 Xanthohumol treatment prevented corticosterone elevation and BDNF reduction in MS rats. (A) 
Corticosterone levels in plasma rise after rats are exposed to an acute stress. (B) MS-induced increase in 
corticosterone release is abolished by treatment with xanthohumol. (C) Baseline levels of corticosterone of rats 
treated with xanthohumol and phlorotannins are significantly lower compared to MS animals. (D) Rats treated 
with xanthohumol displayed higher levels of plasma BDNF compared to the MS-control group. Plasma 
corticosterone was determined using ELISA, and BDNF determination was performed with MSD system. Results 
are expressed as the mean ± SEM (*p < 0.05 versus ‘vehicle’ groups; #p < 0.05; ##p < 0.01 versus ‘CORT’ 
groups). 
3.5 MS induced decreased levels of DA and 5-HIAA in brainstem 
To further determine the effects of early life stress on neurochemistry, and its potential 
implication on the antidepressant and anxiolytic effects of polyphenols, monoamine 
neurotransmitter concentration was measured in the brainstem. MS produced a significant 
reduction of DA and 5-HIAA levels (t20 = 6.121; p = .000 and t22 = 3.934; p = .001 respectively) 
(Fig. 4B and D), reduced 5-HT turnover (t21 = 3.519; p = .002) (Fig. 4C), and increased DA 
turnover (t22 = -2.153; p = .047) (Fig. 4F). In contrast, treatment with phlorotannins increased 










Figure 4 Polyphenols did not prevent MS-induced reductions in brainstem dopamine and 5-HIAA. Monoamine 
neurotransmitters were measured in the brainstem via HPLC. MS animals show depleted concentrations of 
dopamine and 5-HIAA compared to NS-control rats. Phlorotannins diet intervention exerted an increase of 
noradrenaline and 5-HT MS animals, although not significant. Results are expressed as the mean ± SEM (*p < 
0.05; **p < 0.01; ***p < 0.001 versus ‘vehicle’ groups; #p < 0.05 versus ‘CORT’ groups). 
3.6 MS and dietary treatments induced changes in gut bacterial diversity 
To define whether the experimental treatments also altered gut microbiota diversity and 
bacterial abundance, α- and β-diversity analyses were performed. Although no differences in 
richness were found using the Chao1 α-diversity metric (Fig. 5A), Shannon entropy and 
Simpson index both indicate that MS rats treated with phlorotannins showed reduced diversity 
within this group compared to the MS-control experimental group (p = .072 and p < .05, 
respectively) (Fig. 5B and C). In other words, while the total estimated amount of OTUs did 









evenly. On the other hand, principal component analysis (PCA) to measure the diversity among 
groups, indicated that MS and NS control groups were significantly different from each other 
(F4,47 = 2.012; p = .046) (Fig. 5D). In addition, treatments with quercetin, xanthohumol and 
phlorotannins also produced significant changes in β-diversity in terms of Aitchison distance 
compared to MS-control group (F4,47 = 2.012; p = .004; p = .045; p = .046, respectively) (Fig. 
5D). 
3.7 Changes in the gut microbiota composition correlated with MS status 
and polyphenolic diets 
Alteration of the gut microbiota composition has been associated with different mental 
disorders, including major depression and other stress-related psychiatric disorders (Cryan and 
Dinan, 2012). Thus, we examined the differences in the gut microbiota composition of 
maternally separated rats. Significant differences in terms of the relative abundance between 
MS-control and NS-control animals were found in 5 specific bacteria based on effect size 
(Streptococcus; Ruminococcus; Parabacteroides; Rothia; Christensenellaceae; q < .1) (Fig. 
5E). On the other hand, dietary interventions with quercetin and xanthohumol in MS rats 
induced significant changes in the abundance of other bacteria genera when compared to the 
MS-control group. Specifically, quercetin produced a significant increase of Enterorhabdus (q 
< .1), while xanthohumol exerted changes in the abundance of Asteroplasma, 
Lachnospiraceae, and Coprococcus (q < .1) (Fig. 5E). 
3.8 Treatment with phlorotannins and xanthohumol restore MS-induced 
changes in bacteria associated with microbiota-gut-brain pathways 
To investigate the implications of MS-induced changes in gut microbiota composition on 
metabolic pathways associated with the microbiota-gut-brain axis, we performed a functional 
prediction based in previously described GBMs (Valles-Colomer et al., 2019). MS significantly 









tryptophan degradation, quinolinic acid metabolism, nitric oxide metabolism, and p-cresol 
synthesis compared to NS-control group (q < .1) (Fig. 5F). Intriguingly, although quercetin did 
not alter any relevant bacteria, xanthohumol and phlorotannins treatment restored most of the 
changes produced by MS in these bacteria. 
 
Figure 5 MS and polyphenolic diets induced significant changes in gut microbiota composition and diversity. 
(A – C) Chao1, Simpson index and Shannon entropy were used as estimators of bacterial α-diversity. (D) 
Principal component analysis of genus level was performed to estimate the β-diversity between experimental 
groups. (E) Bacterial abundances were significantly altered in MS rats in terms of effect size (q < .1). In contrast, 
xanthohumol and quercetin changed other bacteria compared to MS animals. (F) Functional prediction of GBMs 
was utilised to detect potential microbiota-gut-brain pathways affected by MS or dietary treatments. Colours 
represent effect size, only microbiome features found to be significantly different in at least one comparison are 














3.9 Xanthohumol prevented MS-induced reduction of intestinal SCFAs 
To determine whether the observed changes in the gastrointestinal microbiota composition and 
diversity correlate with alteration in SCFA production, the levels of acetate, propionate, 
butyrate, valerate were determined in caecal content. Interestingly, maternal separation induced 
a significant reduction of acetate (t22 = 2.409; p = .025), propionate (t22 = 2.988; p = .01), 
isobutyrate (t21 = 3.354; p = .006), isovalerate (t21 = 2.779; p = .016), total SCFAs (t21 = 2.228; 
p = .037), and total BCFAs (t21 = 3.181; p = .008). In contrast, phlorotannin treatment 
significantly reversed the MS-induced propionate reduction (F3,38 = 4.646; p = .022), and 
exerted positive effects on isobutyrate, valerate and total levels of BCFAs. 
 
Figure 6 MS rats exhibited lower levels of gut microbiota-derived metabolites (A – H). MS induced significant 
reduction of gut microbiota-derived metabolites including acetate, propionate, isobutyrate and isovalerate, as 
well as decreased total short-chain fatty acids (SCFA) and branched-chain fatty acids (BCFA). Xanthohumol 
treatment ameliorated MS-induced propionate decrease and tends to improve isobutyrate and valerate levels. 
Fatty acid determination was performed through HPLC in caecal content. Results are expressed as the mean ± 











There has been increasing attention given to the potential of nutritional approaches to 
ameliorate the effects of stress (Lakhan and Vieira, 2008; Marzola et al., 2013; Rechenberg 
and Humphries, 2013). In the present study, we tested different naturally-derived polyphenols 
as potential therapeutic strategies for depression and anxiety associated with early life trauma. 
Indeed, the polyphenols quercetin, xanthohumol and phlorotannins exert varying degrees of 
antidepressant- and anxiolytic-like responses in rats subjected to MS. Moreover, dietary 
interventions also modified gut microbial composition and diversity, suggesting that their 
therapeutic effects could be associated with the microbiota-gut-brain axis.  
The MS rat is an excellent model to study the negative effects of early life stress on brain 
function and structure, which are associated with the development of depression and anxiety 
(O'Mahony et al., 2011; Vetulani, 2013). MS in rats induce a robust depressive-like phenotype 
in adult animals, including changes in gut microbiota, dysregulation of the HPA axis, and an 
imbalance in neurotransmitter levels (Aisa et al., 2007; Daniels et al., 2004; Desbonnet et al., 
2010; Liao et al., 2019; O'Mahony et al., 2009). Furthermore, we demonstrated that all 
polyphenolic treatments tend to reverse these depressive-like behaviours. In particular, the 
phlorotannin-enriched diet produced a significant improvement in immobility and swimming 
behaviour in the FST compared to the MS-control group. Although the effect of polyphenols 
has been recently investigated in animal models of stress (Kwatra et al., 2016; Samad et al., 
2018; Yang et al., 2017), to our knowledge there is no data on the effects of dietary intervention 
with polyphenols in animal models of early life stress per se.  
Regarding anxiety, quercetin administration exerted a significant anxiolytic effect in MS 









Similarly, quercetin- and xanthohumol-enriched diets tend to induce anxiolytic effects in the 
OFT, while phlorotannin treatment revealed a significant improvement. Although the concept 
of a potential therapeutic effect of polyphenols in animal models of stress is not completely 
new (Anjaneyulu et al., 2003; Aubry et al., 2019; Hurley et al., 2014), the neurobehavioural 
effects of polyphenols in a model of early-life stress have not to our knowledge been examined 
previously. 
We further investigated the role of the HPA axis in the therapeutic effects of polyphenol 
administration. Accumulated lines of evidence indicate that depressive or chronically stressed 
patients have an over activated HPA axis (Keller et al., 2017; Pariante and Lightman, 2008). 
Similarly, animals subjected to chronic stress possess a dysregulated HPA axis and increased 
baseline levels of glucocorticoids (O'Mahony et al., 2011; Uschold-Schmidt et al., 2012). 
Indeed, we demonstrated that the dietary intervention with xanthohumol significantly reduced 
the exacerbated production of corticosterone in MS animals. 
Next, we demonstrated that treatment with xanthohumol prevented the MS-induced reduction 
in plasma BDNF. BDNF has strongly been implicated in antidepressant activity, and plasma 
BDNF has been shown to reflect aspects of that centrally and to be a biomarker of 
antidepressant effect (Lee and Kim, 2010; Sen et al., 2008; Woelfer et al., 2019). In addition, 
a positive correlation of BDNF levels between blood and brain has been demonstrated in rats 
(Harris et al., 2016; Karege et al., 2002; Sartorius et al., 2009), and a substantial amount of the 
circulating BDNF has been proposed to originate from the CNS itself (Dawood et al., 2007; 
Krabbe et al., 2007; Rasmussen et al., 2009). Although the possible pathways involved in 
BDNF rescue must be further investigated, it is tempting to speculate that the positive effects 









The relationship between stress and the gut microbiota is gaining a lot of attention 
(Bastiaanssen et al., 2020; Foster et al., 2017). Additionally, we have demonstrated that MS is 
able to induce strong changes to the gut microbiota in terms of composition and diversity which 
is in line with previous reports (Moussaoui et al., 2017; O'Mahony et al., 2009). Although, we 
did not detect changes at the α-diversity level, analysis of β-diversity revealed that MS groups 
treated with polyphenols differ from the MS control group. We followed this up by assessing 
differential abundance of bacterial genera between the treatment groups. Notably, only 
xanthohumol and quercetin treatments produced significant changes in certain bacterial genera 
in MS rats, suggesting that some polyphenol-enriched diets have the potential to modify 
bacterial composition in the gastrointestinal system. Several studies have demonstrated the 
capacity of polyphenolic intake to shape the gut microbiota (Etxeberria et al., 2013; Ozdal et 
al., 2016). The fact that all types of polyphenol intake were found to alter β-diversity compared 
to MS control, but only xanthohumol and quercetin yielded differences in the abundances of 
specific genera may suggest that polyphenols induce a general shift in the microbial 
composition, which may be indicative of a change in functionality in the microbiome. 
Therefore, we performed a functional prediction of the gut metagenome and used this to infer 
the abundance of GBMs, metabolic modules that are involved in the microbiota-gut-brain axis 
(Valles-Colomer et al., 2019). Indeed, the analysis predicted that MS is able to increase the 
abundance of GBMs associated with the modulation of several pathways altered in depression 
and other neuropsychiatric disorders, including metabolism of tryptophan (Curzon and 
Bridges, 1970; Oxenkrug, 2010), inositol (Coupland et al., 2005), p-cresol (Persico and 
Napolioni, 2013), quinolinic acid (Steiner et al., 2011), nitric oxide (Dhir and Kulkarni, 2011), 
and glutamate (Murrough et al., 2017; Sanacora et al., 2012). Interestingly, treatment with 
xanthohumol and phlorotannins reversed these predicted MS-induced changes, suggesting that 








important limitation due to the nature of 16S sequencing is that functional analysis can only be 
inferential. Future metabolomics-based studies should address this experimentally. 
In addition, our data revealed that MS rats exhibited decreased production of SCFAs compared 
with the NS-control group. We detected a significant reduction of acetate, propionate, 
isobutyrate, and isovalerate. The production of SCFAs is highly associated with certain 
bacterial populations in the gut, and there is common agreement surrounding the impact of 
SCFAs on human metabolism and health (Morrison and Preston, 2016). Indeed, it is widely 
accepted that SCFAs play a critical role in gut-microbiota-brain communication, and 
consequences for mental health and behaviour (Dalile et al., 2019; Stilling et al., 2016). A 
preclinical study showed that a depression-associated microbiota makeup can impact SCFA 
production (Kelly et al., 2016), and that SCFAs can reverse the enduring effects of stress in a 
mouse model (van de Wouw et al., 2018). In our study, we demonstrated that treatment with 
xanthohumol specifically prevented the reduction of propionate in MS rats. Since the 
xanthohumol diet intervention induced acute changes in bacterial composition of the MS gut 
microbiota, we presume that the changes observed in propionate levels could be a product of 
improved microbial metabolism. 
In conclusion, our present work confirmed that the naturally derived polyphenols xanthohumol, 
quercetin and phlorotannins can alleviate depressive- and anxiety-like behaviours in the rat MS 
model. We further found that treatment with xanthohumol prevented exacerbated production 
of corticosterone after acute stress in MS animals, and reversed MS-induced plasma BDNF 
depletion. In addition, our data revealed that MS-induced behavioural despair correlated with 
significant changes in bacterial composition and diversity, alteration of predicted microbiota-
gut-brain pathways, and reduced SCFA production. Although all polyphenols caused changes 









prevented the reduction of propionate in MS rats. Taken together, our findings present evidence 
of the therapeutic properties of polyphenols and provide a novel insight into the potential 
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